Table 3 Statistics of all echocardiography variables.

From: Clustering of clinical and echocardiographic phenotypes of covid-19 patients

Variable

Cluster 0

Cluster 1

Cluster 2

Cluster 3

p-value

mean ± std/percentage

# of patients

mean ± std/percentage

# of patients

mean ± std/percentage

# of patients

mean ± std/percentage

# of patients

E' Lat

11.32 ± 2.76

126

8.82 ± 2.61

172

6.50 ± 2.01

110

6.55 ± 1.73

57

1.16E-45

E' Sept

8.37 ± 1.83

125

6.92 ± 1.68

171

5.37 ± 1.35

110

5.06 ± 1.16

58

2.68E-45

E/e average

6.98 ± 1.59

126

8.50 ± 3.01

170

12.33 ± 5.56

111

14.35 ± 5.79

58

1.87E-35

E/E' Sept

8.02 ± 1.89

115

9.34 ± 3.09

165

13.15 ± 6.39

104

16.21 ± 6.88

50

3.54E-29

E/E' Lat

6.01 ± 1.58

116

7.62 ± 3.32

164

11.28 ± 5.32

104

12.47 ± 5.33

49

1.02E-28

A

49.99 ± 10.23

125

62.76 ± 17.22

173

76.31 ± 20.72

98

69.13 ± 20.06

45

1.35E-25

At

108.43 ± 25.59

117

85.08 ± 21.33

162

81.26 ± 27.93

95

68.80 ± 19.75

60

3.21E-24

IVSD

7.51 ± 1.90

127

9.08 ± 2.06

176

10.24 ± 2.16

111

9.83 ± 2.29

62

1.89E-21

Diastolic Grade

0.21 ± 0.43

117

0.77 ± 0.99

152

1.41 ± 1.39

93

1.83 ± 1.46

41

9.78E-20

RA Pressure

6.09 ± 2.17

124

7.11 ± 3.09

161

8.19 ± 3.74

105

11.12 ± 4.69

58

1.45E-18

E/A

1.35 ± 0.40

125

1.03 ± 0.32

173

0.87 ± 0.26

98

1.20 ± 0.67

45

1.95E-18

At < 100

33%(38)

115

77%(123)

160

77%(71)

92

93%(52)

56

2.45E-18

LV mass

111.06 ± 36.50

125

151.03 ± 51.31

169

140.04 ± 50.25

108

171.47 ± 67.81

61

3.18E-14

TAPSE

2.39 ± 0.39

123

2.39 ± 0.48

170

2.15 ± 0.48

110

1.89 ± 0.47

61

2.55E-13

LA volume

46.23 ± 17.74

123

59.35 ± 24.03

172

61.43 ± 27.22

109

76.39 ± 29.07

61

4.84E-13

EF

58.58 ± 4.67

127

57.51 ± 5.39

174

58.21 ± 5.85

112

51.44 ± 9.52

59

1.27E-12

LAVI

24.61 ± 9.10

93

30.13 ± 11.43

139

34.86 ± 15.67

87

42.07 ± 17.33

46

2.36E-12

SV

60.28 ± 17.70

126

68.07 ± 16.25

174

54.61 ± 18.06

109

54.05 ± 16.66

62

7.02E-11

LVEDD

43.74 ± 5.72

126

45.90 ± 5.53

177

40.83 ± 6.87

110

46.75 ± 8.23

62

7.62E-11

RVED area

19.89 ± 4.32

99

21.99 ± 4.58

143

18.82 ± 4.70

90

23.65 ± 5.39

56

1.04E-09

LVESD

27.89 ± 4.98

124

29.92 ± 5.81

175

26.77 ± 5.84

106

32.33 ± 9.63

62

9.95E-08

RV S’

11.08 ± 1.94

122

12.03 ± 2.59

173

10.80 ± 3.12

104

9.73 ± 3.02

60

1.06E-07

Bad heart condition (≥ 2)*

1%(1)

128

2%(4)

195

11%(12)

112

18%(13)

71

2.12E-07

RVES area

11.27 ± 3.37

56

13.13 ± 3.97

66

10.67 ± 2.77

50

14.99 ± 5.80

31

6.30E-06

E

64.89 ± 14.21

127

62.52 ± 17.36

178

67.68 ± 25.86

112

77.82 ± 22.56

61

7.66E-06

CO

4.38 ± 1.22

126

5.69 ± 4.45

170

4.03 ± 1.28

107

4.23 ± 1.45

59

7.58E-06

Pericardial fluid

0.07 ± 0.26

127

0.08 ± 0.28

179

0.22 ± 0.42

112

0.30 ± 0.49

61

7.60E-06

E decel time

166.00 ± 35.04

115

180.34 ± 50.32

167

198.18 ± 56.85

102

165.64 ± 55.32

53

1.19E-05

SVI

32.47 ± 9.40

96

34.92 ± 8.70

141

31.04 ± 9.61

86

29.42 ± 9.82

47

1.34E-03

HR at Echo date

73.75 ± 12.35

126

78.92 ± 14.33

174

74.51 ± 15.09

108

80.00 ± 17.51

61

2.98E-03

CI

2.35 ± 0.66

96

3.00 ± 2.74

138

2.31 ± 0.76

84

2.26 ± 0.77

45

8.29E-03

EF Simp

65.10 ± 9.88

104

63.87 ± 12.43

149

63.63 ± 12.32

89

58.31 ± 15.68

49

1.87E-02

RVFAC CALC

45.63 ± 10.31

53

39.98 ± 13.56

64

42.53 ± 9.82

48

40.34 ± 12.56

29

7.16E-02

  1. P-values were computed using ANOVA for continuous variables (in italics) and Chi2 for categorical variables (in bold), and FDR corrected for multiple testing. For the continuous variables mean ± SD values in each cluster are presented. *Bad heart condition (≥ 2) value of 2 or above of at least one of the following: AS, AR, MS, MR, TS, TR, PS, PR.